Form 4 for SGRY Surgery Partners, Inc.
Accepted 2024-12-16 00:00:00 ET · period of report 2024-12-12 · accession 0001638833-24-000149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-16 | 2024-12-12 | SGRY | Evans Jason Eric | CEO | M - OptEx | $11.54 | +16.5K | 476.2K | +4% | +$190.4K |
| D | 2024-12-16 | 2024-12-12 | SGRY | Evans Jason Eric | CEO | M - OptEx | $0.00 | -16.5K | 483.5K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-12 | M | A | 16,500 | $11.54 | 476,170 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-12-12 | M | D | 16,500 | $0.00 | 483,500 | D | $11.54 · — to 2029-04-01 | 16,500 Common Stock | (F1) The option to purchase shares is fully vested. |